Lead sponsor
Affiris AG
6 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
6
Trials led
0
Ongoing
625
Total enrollment
34
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
4
Phase 2
2
Trials by status
Completed
5
Terminated
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Clinical- and Immunological Activity, Safety and Tolerability of Different Doses / Formulations of AFFITOPE AD02 in Early Alzheimer's DiseaseAlzheimer's diseasePh 2Completed335
Follow-up Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in AFF006Age 50-85Ph 2Terminated194
Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's DiseaseAlzheimer's diseasePh 1Completed24
Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's DiseaseAlzheimer's diseasePh 1Completed24